D3 BIO Overview
Upcoming Projects (D3 BIO)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (D3 BIO)
-
Looking at the Future of KRAS Inhibition in NSCLC Based on AACR 2026 Data from Revolution Medicines (Zoldonrasib), D3 Bio (Elisrasib) and Astellas (Setidegrasib)
Tickers: RVMD, ALPMF, D3 Bio
Executed On: May 05, 2026 at 05:00 PM EDT
Upcoming & Overdue Catalysts (D3 BIO)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (D3 BIO)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
